DCU Researchers Discover New Method for Cancer Treatments

By Steven Galvin - Last update

Get Daily news and updates directly to your Email

Researchers at Dublin City University (DCU) and Chalmers University of Technology (CUT), Sweden, have discovered a new method – called ‘Click and Cut’ – to prepare DNA damaging drug molecules. The long-term goal of the work aims to provide effective new personalised cancer treatments with lower side effects.

‘Click and Cut’ and involves the attachment of metal ion binding groups to a central scaffold using click chemistry. Using this approach, the team prepared a library of drug candidates and identified a lead agent with high potential for treating human cancer.

Explore Dublin City University (DCU) for postgraduate courses on Postgrad.ie.

Metal-based drugs deliver first-line treatment against many forms of cancer, but resistance often builds up leading to their inactivation. To widen treatment possibilities, particularly against difficult-to-treat cancers such as triple-negative breast cancer or glioblastoma multiforme, new therapies with improved or evasive modes of action are highly sought after.

To address this challenge, a DCU team of researchers led by Dr. Andrew Kellett developed the ‘Click and Cut’ method and screened the resulting drug library together with different types of metal ions. From the entire screen, one compound was identified to bind strongly with copper ions and produce a unique type of DNA damage that is not possible to achieve with existing metal-based drugs.

In collaboration with Prof. Fredrik Westerlund and his team at CUT, the compound was then identified to produce DNA damage within primary human cells. By isolating the DNA from these cells, single molecule imaging was performed to visualise the amount of damage and the type of DNA repair (base excision repair – BER) enzymes activated in response. The results were encouraging and showed the compound could produce a high amount of specific damage which placed it in a unique chemotherapeutic class.

Dr. Andrew Kellett, Associate Professor of Inorganic and Medicinal Chemistry in DCU School of Chemical Sciences, Principal Investigator of Biodesign Europe, and Funded Investigator of the SSPC and CÚRAM SFI Research Centres, is the corresponding author of the study. The paper “Click and Cut: A Click Chemistry Approach to Developing Oxidative DNA Damaging Agents” has just appeared in the journal Nucleic Acids Research and is an open access publication.

DCU Researchers Discover New Method for Cancer Treatments

Speaking about the discovery, Dr. Andrew Kellett said:

“These results are promising and indicate a new avenue for preparing unique types of drug molecules. Although click chemistry has an extensive range of applications—particularly in the field of nucleic acid chemistry—it has not yet been widely considered as a way to construct DNA-damaging metallodrugs.”

The research team now aims to expand this method and develop new therapies directed to specific cancer-causing genes. Plans are also underway to develop second generation chemotherapeutics with improved properties.



Steven Galvin

'The Letters of John McGahern'
TUS Recognised for Commitment to Advancing Gender Equality


Leave a Reply

Your email address will not be published. Required fields are marked *

We'd love to send you the latest news and articles about evening classes, further learning and adult education by email. We'll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

Comments and Reviews Policy